Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07CIX
|
|||
Former ID |
DIB006803
|
|||
Drug Name |
FM-101
|
|||
Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90.0] | Investigative | [1] | |
Company |
Femta Pharmaceuticals Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin 6 receptor (IL6R) | Target Info | Modulator | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
HIF-1 signaling pathway | ||||
PI3K-Akt signaling pathway | ||||
Jak-STAT signaling pathway | ||||
Hematopoietic cell lineage | ||||
Non-alcoholic fatty liver disease (NAFLD) | ||||
Reactome | MAPK3 (ERK1) activation | |||
MAPK1 (ERK2) activation | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Senescence and Autophagy in Cancer | ||||
IL-6 signaling pathway | ||||
Differentiation Pathway | ||||
Interleukin-6 signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2310). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.